Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 O-I Glass, Inc. OI Dec 3, 2021 11.40 -1.30   
 O2Micro International Limited - American Depositary Shares OIIM Dec 3, 2021 5.09 -1.74   
 Oak Street Health Inc OSH Dec 3, 2021 28.40 -8.09   
 Oak Valley Bancorp (CA) OVLY Dec 3, 2021 17.30 -1.03   
 Oaktree Acquisition Corp II OACB Dec 3, 2021 9.91 +0.52   
 Oaktree Capital Group LLC 6.55% PRF PERPETUAL USD 25 - Ser B OAK-B Dec 3, 2021 26.54 -0.39   
 Oaktree Capital Group LLC 6.625% PRF PERPETUAL USD 25 - Ser OAK-A Dec 3, 2021 26.28 -0.53   
 Oaktree Specialty Lending Corporation OCSL Dec 3, 2021 7.40 -0.67   
 Oasis Midstream Partners LP - Common Units, Representing Lim OMP Dec 3, 2021 22.29 +2.48   
 Oasis Petroleum Inc. OAS Dec 3, 2021 117.02 -1.18   
 Oatly Group AB - American Depositary Shares OTLY Dec 3, 2021 8.00 -2.79   
 Oblong Inc. OBLG Dec 3, 2021 1.11 -13.67   
 ObsEva SA - OBSV Dec 3, 2021 2.02 -4.27   
 OCA Acquisition Corp. - Class A OCAX Dec 3, 2021 9.93 +0.05   
 OCA Acquisition Corp. - Unit OCAXU Dec 3, 2021 10.14 0.00   
 Occidental Petroleum Corporation OXY Dec 3, 2021 29.16 -1.65   
 Ocean Bio-Chem, Inc. OBCI Dec 3, 2021 9.20 -2.54   
 Ocean Power Technologies, Inc. OPTT Dec 3, 2021 1.60 -8.05   
 Oceaneering International, Inc. OII Dec 3, 2021 11.17 -1.93   
 OceanFirst Financial Corp. OCFC Dec 3, 2021 20.94 -1.60   
 OceanFirst Financial Corp. - Depositary Shares OCFCP Dec 3, 2021 27.73 0.00   
 OceanTech Acquisitions I Corp. - Units OTECU Dec 3, 2021 10.39 +0.29   
 Oconee Federal Financial Corp. OFED Dec 3, 2021 23.51 -0.38   
 Ocugen, Inc. OCGN Dec 3, 2021 5.76 -8.72   
 Ocular Therapeutix, Inc. OCUL Dec 3, 2021 6.16 -5.38   
 Ocuphire Pharma, Inc. OCUP Dec 3, 2021 3.57 -4.80   
 Ocwen Financial Corporation NEW OCN Dec 3, 2021 34.53 -1.68   
 Odonate Therapeutics, Inc. ODT Dec 3, 2021 1.52 -3.18   
 Odyssey Marine Exploration, Inc. OMEX Dec 3, 2021 5.69 -4.37   
 Office Properties Income Trust - OPI Dec 3, 2021 23.59 -1.21   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK